Structures by: Nagaraj B.
Total: 30
9-[3-(Dimethylamino)propyl]-10,10-dimethyl-9,10-dihydroanthracen-9-ol
C21H27NO
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 2 o175
a=11.79596(9)Å b=9.17559(7)Å c=16.75788(13)Å
α=90° β=92.2372(7)° γ=90°
2-benzoyloxy-5-methylbenzophenone
C21H16O3
Acta Crystallographica Section E (2004) 60, 10 o1889-o1891
a=9.2068(5)Å b=9.7961(5)Å c=10.1375(6)Å
α=94.732(4)° β=112.570(5)° γ=102.194(4)°
Morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)- 4-methylhex-4-enoate
C23H31NO7
Acta Crystallographica Section E (2004) 60, 12 o2223-o2224
a=20.784(2)Å b=9.3210(6)Å c=11.9373(11)Å
α=90.00° β=106.719(7)° γ=90.00°
C18H24NO3,Cl
C18H24NO3,Cl
Acta Crystallographica Section E (2004) 60, 12 o2228-o2229
a=12.0767(11)Å b=19.3499(12)Å c=7.8018(7)Å
α=90.00° β=107.482(7)° γ=90.00°
6-fluoro-3-(4-piperidinio)benz[d]isoxazole chloride
C12H14FN2O,Cl
Acta Crystallographica Section E (2005) 61, 2 o356-o358
a=13.020(6)Å b=6.608(3)Å c=15.119(7)Å
α=90.00° β=113.109(7)° γ=90.00°
10-Methoxydibenz[b,f]azepine-5-carboxamide
C16H14N2O2
Acta Crystallographica Section E (2005) 61, 6 o1760-o1761
a=8.8003(2)Å b=9.2012(2)Å c=9.3735(3)Å
α=64.6999(16)° β=76.0520(15)° γ=83.7398(18)°
N,N-Bis(2-cyanoethyl)-p-toluenesulfonamide
C13H15N3O2S
Acta Crystallographica Section E (2005) 61, 7 o1965-o1966
a=5.7994(7)Å b=9.1494(12)Å c=12.8573(15)Å
α=92.152(10)° β=94.282(10)° γ=90.551(10)°
5-aminophthalide
C8H7NO2
Acta Crystallographica Section E (2005) 61, 2 o343-o344
a=4.6858(7)Å b=8.2573(9)Å c=17.627(2)Å
α=90.00° β=90.00° γ=90.00°
5-bromophthalide
C8H5BrO2
Acta Crystallographica Section E (2005) 61, 2 o345-o346
a=15.4063(19)Å b=6.0861(6)Å c=15.4426(16)Å
α=90.00° β=93.950(9)° γ=90.00°
4-[2-(5-Ethylpyridin-2-yl)ethoxy]benzaldehyde oxime
C16H18N2O2
Acta Crystallographica Section E (2005) 61, 3 o751-o752
a=16.4538(19)Å b=5.3346(5)Å c=17.952(2)Å
α=90.00° β=114.709(9)° γ=90.00°
5-[4'-(Bromomethyl)biphenyl-2-yl]-2-trityl-2H-tetrazole
C33H25BrN4
Acta Crystallographica Section E (2005) 61, 3 o767-o768
a=10.6150(6)Å b=14.9140(5)Å c=17.3961(9)Å
α=90.00° β=102.263(4)° γ=90.00°
6,6,8a-Trimethyl-3a,6,7,8a-tetrahydrobenzo[b]furo[3,2-d]furan-2,4(3H,5H)-dione
C13H16O4
Acta Crystallographica Section E (2005) 61, 4 o1041-o1042
a=9.4853(3)Å b=10.2904(2)Å c=12.2872(4)Å
α=90.00° β=90.00° γ=90.00°
4'-[2-Butyl-4-chloro-5-(hydroxyiminomethyl)-1H-imidazol-3-ylmethyl]biphenyl- 2-carbonitrile
C22H21ClN4O
Acta Crystallographica Section E (2005) 61, 3 o714-o715
a=7.6974(6)Å b=7.8682(6)Å c=19.1907(16)Å
α=79.823(6)° β=84.248(7)° γ=64.220(6)°
2,2'-Diaminodibenzyl
C14H16N2
Acta Crystallographica Section E (2005) 61, 4 o843-o845
a=5.4716(4)Å b=12.4800(10)Å c=16.6950(10)Å
α=90.00° β=90.00° γ=90.00°
10-Methoxy-5H-dibenz[b,f]azepine
C15H13NO
Acta Crystallographica Section E (2005) 61, 6 o1757-o1759
a=54.925(11)Å b=5.8189(12)Å c=21.628(4)Å
α=90.00° β=98.14(3)° γ=90.00°
1-(10,11-Dihydrodibenz[b,f]azepin-5-yl)ethanone
C16H15NO
Acta Crystallographica Section E (2005) 61, 6 o1609-o1610
a=9.5674(2)Å b=11.7020(3)Å c=22.2785(4)Å
α=90.00° β=90.00° γ=90.00°
N-[(2'-Cyanobiphenyl-4-yl)methyl]-L-valine methyl ester hydrochloride
C20H23N2O2,Cl
Acta Crystallographica Section E (2004) 60, 11 o2160-o2162
a=15.6095(8)Å b=6.8297(4)Å c=18.6854(9)Å
α=90.00° β=103.739(4)° γ=90.00°
1-(4-Fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
C15H10FNO
Acta Crystallographica Section E (2004) 60, 12 o2225-o2227
a=14.606(2)Å b=5.8056(6)Å c=27.037(4)Å
α=90.00° β=99.032(11)° γ=90.00°
2,2'-dinitrodibenzyl
C14H12N2O4
Acta Crystallographica Section E (2004) 60, 12 o2455-o2456
a=7.5678(8)Å b=14.4964(16)Å c=5.9874(5)Å
α=90.00° β=108.607(6)° γ=90.00°
2,2'-Dipropylmalonic acid
C9H16O4
Acta Crystallographica Section E (2005) 61, 1 o151-o153
a=7.6830(10)Å b=8.5490(10)Å c=9.3820(10)Å
α=76.249(2)° β=70.140(2)° γ=72.355(2)°
2-Butyl-4-chloro-1-(4-nitrobenzyl)-1H-imidazole-5-carboxaldehyde
C15H16ClN3O3
Acta Crystallographica Section E (2004) 60, 12 o2520-o2521
a=8.3007(5)Å b=12.2295(6)Å c=16.5605(10)Å
α=103.420(4)° β=95.561(3)° γ=106.758(3)°
Phthaloyl amlodipine
C28H27ClN2O7
Acta Crystallographica Section E (2005) 61, 1 o174-o175
a=8.0458(9)Å b=10.5193(11)Å c=15.7386(17)Å
α=98.073(9)° β=90.542(9)° γ=103.744(8)°
2-methyl-1-(1,2,3,9-tetrahydro-9-methyl-4-oxo-4H-carbazol-3-ylmethyl)-1H- imidazol-3-ium chloride dihydrate
C18H20N3O,Cl,2H2O
Acta Crystallographica Section E (2005) 61, 1 o47-o48
a=15.0216(13)Å b=9.6464(8)Å c=12.6545(10)Å
α=90.00° β=100.708(6)° γ=90.00°
Pioglitazone hydrochloride
C19H21N2O3S,Cl
Acta Crystallographica Section E (2005) 61, 1 o154-o155
a=10.0696(17)Å b=9.4318(16)Å c=10.1752(19)Å
α=90.00° β=95.178(14)° γ=90.00°
2-(3-Chloropropyl)-2,3-dihydro-1H-isoindole-1,3-dione
C11H10ClNO2
Acta Crystallographica Section E (2005) 61, 4 o928-o929
a=4.5421(4)Å b=15.3996(15)Å c=15.3471(13)Å
α=90.00° β=96.605(7)° γ=90.00°
4'-(2-Butyl-4-chloro-5-formylimidazol-1-ylmethyl)biphenyl-2-carbonitrile
C22H20ClN3O
Acta Crystallographica Section E (2005) 61, 4 o1193-o1195
a=8.9729(4)Å b=22.6232(9)Å c=9.9288(5)Å
α=90.00° β=106.427(4)° γ=90.00°
1-(Carbamoylmethyl)cyclohexanecarboxylic acid
C9H15NO3
Acta Crystallographica Section E (2005) 61, 4 o884-o885
a=13.4973(5)Å b=8.0905(2)Å c=8.8358(3)Å
α=90.00° β=102.627(2)° γ=90.00°
Trityl losartan
C41H37ClN6O
Acta Crystallographica Section C (2004) 60, 11 o821-o823
a=8.6962(3)Å b=20.5493(6)Å c=21.7392(5)Å
α=69.597(2)° β=88.587(2)° γ=78.962(3)°
2-butyl-4-chloro-1-(6-methyl-1,3-benzodioxol-5-ylmethyl)-1H-imidazole- 5-carboxaldehyde
C17H19ClN2O3
Acta Crystallographica Section C (2005) 61, 3 o177-o180
a=12.4899(5)Å b=9.4887(3)Å c=14.1018(5)Å
α=90.00° β=94.3190(10)° γ=90.00°
1-(2-bromo-4,5-dimethoxybenzyl)-2-butyl-4-chloro-1H-imidazole-5-carboxaldehyde
C17H20BrClN2O3
Acta Crystallographica Section C (2005) 61, 3 o177-o180
a=8.547(2)Å b=10.308(2)Å c=10.611(2)Å
α=91.654(4)° β=100.667(4)° γ=93.623(3)°